KAKathleen M. Akgun

Kathleen M. Akgun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kathleen M. Akgun has a total of 234 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Private equity and the corporatization of health care: implications for pulmonary, critical care, and sleep medicine

    by Donald R Sullivan, Sneha Kannan, Folashade Afolabi, Steven Q Davis, Indira Gurubhagavatula, Vidya Krishnan, Nandini Sarma, Jane M Zhu, Nicholas A Kolaitis, Kathleen M Akgün

    Donald R Sullivan, MD, MA, MCR, Sneha Kannan, MD, MS, Folashade Afolabi, M.D, Steven Q Davis, MD MS MA, Indira Gurubhagavatula, MPH, MD, Vidya Krishnan, MH

  • Top Cited Papers

    A “PalliPulm” Framework to Improve Palliative Care Education and Practice in Pulmonary-Critical Care Medicine: An Official American Thoracic Society Workshop Report

    by Anand S Iyer, Kathleen M Akgün, Brynn Bowman, Crystal E Brown, Laura Dingfeld, Doranne Donesky, Tracy Fasolino, Betty Ferrell, Rebecca Anna Gersten, Joanna L Hart, et al.

    Despite numerous calls to action, palliative care remains inadequately integrated into pulmonary-critical care medicine (PCCM) practice and is de-emphasized in PCCM education. Barriers to specialty palliative care demonstrate a clear need for efficient and effective primary palliative care delivered by PCCM clinicians with advanced training. This American Thoracic Society Workshop Report builds on our policy statement on the proactive integration of palliative care in serious respiratory illness with two goals: 1) Develop a scalable “PalliPulm” framework to improve palliative care education and practice in PCCM, and 2) Inform palliative care-focused education and training programs to guide future PCCM initiatives. We convened an interdisciplinary and interprofessional group of experts between May 2024-February 2025 over 4 phases: 1) Hybrid workshop; 2) Virtual breakout groups; 3) Nominal group technique and rapid qualitative analysis; and 4) Workshop report development. We identified core primary palliative care skills that PCCM trainees and clinicians should obtain and prioritized the most essential skills, ie, symptom management, serious illness communication, and caregiver support in ambulatory settings and serious illness communication, symptom management, palliative care fundamentals, and end of life care in inpatient settings. We describe pragmatic ways to integrate palliative care into PCCM education and offer advanced educational resources. We provide recommendations for framing palliative care to patients and caregivers, illustrate ways to deliver culturally appropriate palliative care, and offer guidance for the future. This report guides PCCM leaders, trainees, and clinicians to establish scalable PalliPulm educational and practice initiatives and improve its integration into practice.


  • Open Access

    How much is too much? A medication use evaluation of VA ICU sedation practice during the COVID-19 pandemic

    by Ian C. Murphy, Kelly Bryan, Muriel Burk, Rong Jiang, Francesca Cunningham, Sarah Providence, Elizabeth Rightnour, Sarah Zavala, Kathleen Morneau, Trisha Exline, et al.

    OBJECTIVES: Early data suggested higher sedative requirements for ventilated COVID+ patients, deviating from established guidelines. We assessed the relationship between sedative use and outcomes in mechanically ventilated Veterans during the COVID-19 pandemic. Design: Retrospective Medication Use Evaluation Setting: National Sample of 13 Distinct VA Medical Center Intensive Care Units Patients: Critically ill Veteran patients requiring mechanically ventilation for ≥2 days Interventions: None. Measurements and main results: The proportion of patients receiving fentanyl, midazolam and propofol was higher during COVID years. Compared with pre-COVID, median fentanyl dose was higher during Years 1 and 2 (1575mcg [(IQR) 1000–1650] vs. 1900 [1250–3000] vs. 1910 [1150–3500]). Adjuvant antipsychotics use was relatively low but tended to increase over time (pre = 10.5% vs. Year 1 = 12.3% vs. Year 2 = 14.1%). Most patients started on antipsychotics in the ICU were continued on the drug after extubation. Mortality was higher during COVID years (pre = 26.9% vs. 1 = 36.8% and 2 = 35.9%). In stratified analyses by COVID status years 1–2 (n = 79, 27%), a higher proportion of COVID+ patients received fentanyl (96% vs. 84%) and propofol (90% vs. 77%) and at higher doses (fentanyl = 1650mcg vs. 2688mcg median cumulative dose; propofol maximum infusion rate = 30 mc/kg/min (20–50) vs. 40 (25–50)). Sedative doses were similar to pre-COVID among non-COVID patients. Anti-psychotics were more frequently continued post extubation among COVID+ (34.6% vs. non-COVID+=14.9%). COVID+ patients were also less likely to have awakening and breathing trials at 48 hours after intubation (18% vs. 46%). Conclusions: Sedative use and dosing increased during the first two years of COVID compared to pre-COVID, especially for COVID+ patients. The sustained elevated levels of fentanyl use in Year 2 suggests possible ‘therapeutic creep’ away from guideline-concordant practices for COVID+ patients. Antipsychotic prescription during intubation and following extubation was also more common among COVID + . These findings could inform development and implementation of safer sedation practices across VA ICUs during respiratory pandemics.

  • Open Access

    Concurrent Alcohol Use and the Relative Risk of Community‐Acquired Pneumonia Associated With Anticholinergic and Non‐Anticholinergic Neurocognitively Active Medication Receipt: A National Nested Case–Control Study Among US Veterans

    by William H. Wang, Kristina Crothers, Kathleen M. Akgün, Kirsha S. Gordon, Maria C. Rodriguez‐Barradas, Julie A. Womack, Jennifer Thompson, Amy C. Justice, Christopher T. Rentsch

    Purpose: Anticholinergic medications and alcohol each independently increase the risk of community‐acquired pneumonia (CAP). Whether non‐anticholinergic neurocognitively active medications also increase risk, and if alcohol modifies these associations, remains unclear. Methods: We conducted a nested case–control study using Veterans Aging Cohort Study (VACS)‐National data. We identified 157 185 incident CAP cases requiring hospitalization between 2010 and 2022. Cases were matched 1:5 to controls without CAP on demographics, cohort entry date, and dwell time in the underlying cohort study using incidence density (risk‐set) sampling. CAP index date was hospital admission for cases and the equivalent follow‐up date for controls. Primary exposures were receipt of anticholinergic and non‐anticholinergic neurocognitively active medications within 90 days prior to the index date. Concurrent alcohol use was based on self‐reported measures in the year prior to the index date. We estimated odds ratios (ORs) for associations between medication use, alcohol consumption, and CAP using logistic regression, adjusting for confounders. Results: Median age was 69 years (interquartile range 62–78); 97% were male. Both medication types were independently associated with increased odds of CAP (anticholinergic: OR 1.62, 95% CI 1.57–1.67; non‐anticholinergic: OR 1.61, 95% CI 1.57–1.66). Concurrent alcohol use modified these associations. For anticholinergics, ORs were 1.74 (95% CI 1.66–1.83) for at‐risk consumption and 2.13 (95% CI 1.96–2.31) for hazardous/binge consumption. For non‐anticholinergics, ORs were 1.74 (95% CI 1.67–1.81) and 2.20 (95% CI 2.06–2.34), respectively. Conclusions: Non‐anticholinergic neurocognitively active medications showed similar CAP association patterns as anticholinergics, with the highest odds among those consuming alcohol. These findings highlight the need for caution when prescribing these medications and incorporating alcohol use into risk–benefit assessments.


  • Privacy and dignity for undocumented people? Clinicians’ duties and responses to patient immigration status inquiries

    by David M Chooljian, Aaron D Baugh, Erin DeMartino, Matthew Griffith, Eugene Wesley Ely, Kathleen M Akgün


  • Open Access

    Medical associations’ guidance on caring for patients experiencing incarceration in the United States

    by Nicholas V. Nguyen, Tyler A. Nguyen, Kathleen M. Akgün, Amen Sergew, Matthew F. Griffith, Erin S. DeMartino

    The United States has one of the highest incarceration rates in the world. Carceral status can complicate clinical encounters in community and academic settings for an already medically vulnerable population. While it is likely physicians will encounter patients experiencing incarceration in their practice, there are few educational opportunities dedicated to ensuring delivery of healthcare that protects patient dignity, autonomy, and privacy. Professional medical associations can play a role in filling this physician knowledge gap. The goal of this analysis is to catalogue and analyze the current landscape of official medical association documents addressing healthcare of people experiencing incarceration. A systematic Internet search was conducted of American Medical Association House of Delegates associations and their existing documents. Out of 116 associations included in the systematic search, 16 groups published materials on incarceration. From these 16 associations, 44 documents were identified and coded thematically. Documents served four main purposes: education on incarceration (28/44), clinical guidance (25/44), logistical guidance (27/44), and policy advocacy (30/44). Common topics included medical conditions of people experiencing incarceration, patient factors antecedent to incarceration, and specialty or population-specific information. Few medical associations have published material on incarceration and the paucity of pragmatic clinical guidance was particularly pronounced. A lack of resources from medical associations can lead to variability and lapses in best healthcare practices when treating patients experiencing incarceration. Medical associations should consider developing guidance for clinicians to maximize this patient population’s autonomy and dignity.


  • Agreement Between Self-Reported and Proxy-Reported Pain in Veterans With Advanced Heart Failure

    by Kathleen M. Akgün, Ling Han, Yan Zhan, Erica A. Abel, Shelli L. Feder

    Background: Self-reported pain is frequently reported among patients with advanced heart failure (aHF). Agreement between patients’ pain assessment and their proxies have shown inconsistent results. We examined agreement between documented patient self-report and family-reported pain scores for Veterans with aHF towards the end of life (EOL). Methods: We conducted a retrospective cohort study of aHF patients who died between 2018-2020 while inpatient at one of 83 Veterans Affairs Medical Centers (VAMC) and whose families completed a Beavered Family Survey (BFS) (n = 1045). BFS is a nationally distributed questionnaire assessing family-reported quality of inpatient EOL care at VAMCs. Averaged daily patient-reported numeric rating scale (NRS) pain scores over the last 30 and 7-days of life were categorized as: no pain (NRS = 0), mild (NRS = 1-3), moderate (NRS = 4-6), and severe (NRS = 7-10). NRS categories were compared to family-reported pain using responses to two BFS items (ever pain; some pain). Agreement between NRS categories and family-reported pain was assessed using Cohen’s kappa coefficient statistic. Results: There was moderate agreement between 30-day NRS severe pain and BFS ever pain and fair agreement for the last 7 days. Mild pain showed no-to-slight agreement compared to both BFS pain outcomes. Substantial or complete agreement was not identified between NRS and BFS. Agreement was generally stronger for last 30 vs 7 days of life. Conclusions: Agreement between aHF patients’ and their families’ pain reporting was moderate for the worst pain categories only and stronger with longer time for patient-reported pain. These findings suggest limitations using proxy-reported pain in patients with aHF.

  • Patients' and Caregivers' Perspectives on the Role of Ambulatory Specialty Palliative Care for People With Heart Failure

    by Dora Lendvai, Yan Zhan, Dio Kavalieratos, Lynne Iannone, Kathleen M. Akgün, Larry A. Allen, David Bekelman, Mary Ersek, Nathan E. Goldstein, Carol Luhrs, et al.


  • Pain Outcomes Among Medical Centers With High vs Low Specialist Palliative Care Reach Among People With Heart Failure

    by Shelli L. Feder, L. Han, Yan Zhan, Erica A. Abel, Kathleen M. Akgün

    Background: Pain affects more than 60% of people with heart failure (HF), with increasing frequency and severity towards the end of life (EOL). We examined if family-rated pain near EOL was associated with rates of specialist palliative care (SPC) among patients with HF. Methods: We conducted a retrospective cohort study among 1095 decedents with advanced HF (aHF = ≥2 hospitalizations) from 83 Veterans Affairs Medical Centers (VAMCs) between 2018-2020. We used multilevel logistic regression to derive facility rates of predicted SPC for each VAMC adjusting for demographic and clinical characteristics. We examined associations between VAMCs in the top 20% (vs bottom 80%) of SPC rates and family-reported pain at the EOL from the Bereaved Family Survey and the interaction between receiving SPC and VAMC-level SPC rates on study outcomes. Analyses were conducted using generalized linear models, adjusting for demographic, clinical, and facility covariates. Results: The sample was 98% male, 73% White, and 20% Black, with a mean age of 79.7+/−10.3 years. Over 77% of the sample had uncontrolled pain at the EOL. In adjusted models, there was no association between family-reported pain and VAMC rates of SPC (Odds Ratio = 1.082, 95% Confidence Interval = 0.706-1.659). Receipt of SPC did not change this relationship (p-interaction = .405). Conclusion: Families of people with aHF cared for in VAMCs with high rates of SPC were as likely to report uncontrolled pain relative to people cared for in VAMCs with lower SPC rates. Research is needed to identify delivery and organizational features associated with improved pain control at the EOL among this symptomatic population.

  • Open Access

    Factors Associated With Influenza Vaccination in a National Veteran Cohort

    by Alissa S. Chen, Melissa M. Farmer, Ling Han, Tessa Runels, Brett Bade, Kristina Crothers, Lori A. Bastian, Isabel S. Bazan, Bevanne A. Bean-Mayberry, Cynthia A. Brandt, et al.